Is This The Chart That Scared Yellen Capital Out Of Biotechs?

Nope, no bubble here at all. Biotechs driven by fun-durr-mentals like everything else…*)As Bloomberg reports, perhaps there is a limit it this insanity. Demand for options tied to declines in an exchange-traded fund tracking the companies rose to the highest level in three years relative to bullish ones, according to data compiled by Bloomberg. The Nasdaq Biotechnology Index has risen¬†[…]